Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Collagen/bone growth factor - Millenium Biologix Corporation

Drug Profile

Collagen/bone growth factor - Millenium Biologix Corporation

Alternative Names: BCSP; BCSS; Bone and Cartilage Stimulating Peptides - Millenium Biologix; Bone cell stimulating substances; Primacoll

Latest Information Update: 02 Jun 2010

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Millenium Biologix Corporation
  • Class Biopolymers
  • Mechanism of Action Collagen stimulants; Intercellular signalling peptide and protein stimulants; Osteogenesis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Bone disorders

Most Recent Events

  • 16 Nov 2005 Clinical trials in Bone regeneration in Canada (Intralesional)
  • 16 Nov 2005 Millenium Biologix Corporation voluntarily withdrew its submission to Health Canada for Primacoll™ for bone regeneration during the second quarter of 2005
  • 21 Sep 2005 Launched for Bone regeneration in Europe (Intralesional) - first global launch
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top